| Dr Daniel Benedict Schmolze, MD | |
|
1500 Duarte Rd, Duarte, CA 91010-3012 | |
| (626) 256-4673 | |
| Not Available |
| Full Name | Dr Daniel Benedict Schmolze |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 13 Years |
| Location | 1500 Duarte Rd, Duarte, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043699630 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hoag Memorial Hospital Presbyterian | Newport beach, CA | Hospital |
| Mission Hospital Regional Med Center | Mission viejo, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| City Of Hope Medical Foundation | 3779751656 | 686 |
News Archive
Raptor Pharmaceutical Corp., today announced that the first patient has been dosed in its Phase 2 clinical trial of DR Cysteamine for the potential treatment of Huntington's Disease. The Phase 2 clinical trial is being conducted under a previously announced collaboration agreement with The Centre Hospitalier Universitaire d'Angers ("CHU d'Angers"), which has commenced enrolling patients at eight clinical sites throughout France.
Teva Neuroscience today announced results at the 62nd American Academy of Neurology Annual Meeting which demonstrated that eliminating barriers to neutralizing antibodies (NAbs) testing significantly impacted multiple sclerosis (MS) treatment choices in patients receiving interferon beta (IFNβ) therapies.
By examining how sounds are registered during the process of learning, UC Irvine neurobiologists have discovered a neural coding mechanism that the brain relies upon to register the intensity of memories based on the importance of the experience.
A primary characteristic of autism spectrum disorders (ASD) is impairments in social-communication skills. Children and adolescents with social-communication problems face difficulty understanding, interacting and relating with others. University of Missouri researchers found that children who receive more intensive therapy to combat these impairments, especially at early ages, achieve the best outcomes.
More than 90 percent of Americans age 65 and older have prescription drug coverage today, compared to 76 percent who were covered in 2004, according to a University of Michigan analysis.
› Verified 3 days ago
| Entity Name | City Of Hope Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871886366 PECOS PAC ID: 3779751656 Enrollment ID: O20110720000244 |
News Archive
Raptor Pharmaceutical Corp., today announced that the first patient has been dosed in its Phase 2 clinical trial of DR Cysteamine for the potential treatment of Huntington's Disease. The Phase 2 clinical trial is being conducted under a previously announced collaboration agreement with The Centre Hospitalier Universitaire d'Angers ("CHU d'Angers"), which has commenced enrolling patients at eight clinical sites throughout France.
Teva Neuroscience today announced results at the 62nd American Academy of Neurology Annual Meeting which demonstrated that eliminating barriers to neutralizing antibodies (NAbs) testing significantly impacted multiple sclerosis (MS) treatment choices in patients receiving interferon beta (IFNβ) therapies.
By examining how sounds are registered during the process of learning, UC Irvine neurobiologists have discovered a neural coding mechanism that the brain relies upon to register the intensity of memories based on the importance of the experience.
A primary characteristic of autism spectrum disorders (ASD) is impairments in social-communication skills. Children and adolescents with social-communication problems face difficulty understanding, interacting and relating with others. University of Missouri researchers found that children who receive more intensive therapy to combat these impairments, especially at early ages, achieve the best outcomes.
More than 90 percent of Americans age 65 and older have prescription drug coverage today, compared to 76 percent who were covered in 2004, according to a University of Michigan analysis.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel Benedict Schmolze, MD Po Box 512185, Los Angeles, CA 90051-0185 Ph: (626) 775-3514 | Dr Daniel Benedict Schmolze, MD 1500 Duarte Rd, Duarte, CA 91010-3012 Ph: (626) 256-4673 |
News Archive
Raptor Pharmaceutical Corp., today announced that the first patient has been dosed in its Phase 2 clinical trial of DR Cysteamine for the potential treatment of Huntington's Disease. The Phase 2 clinical trial is being conducted under a previously announced collaboration agreement with The Centre Hospitalier Universitaire d'Angers ("CHU d'Angers"), which has commenced enrolling patients at eight clinical sites throughout France.
Teva Neuroscience today announced results at the 62nd American Academy of Neurology Annual Meeting which demonstrated that eliminating barriers to neutralizing antibodies (NAbs) testing significantly impacted multiple sclerosis (MS) treatment choices in patients receiving interferon beta (IFNβ) therapies.
By examining how sounds are registered during the process of learning, UC Irvine neurobiologists have discovered a neural coding mechanism that the brain relies upon to register the intensity of memories based on the importance of the experience.
A primary characteristic of autism spectrum disorders (ASD) is impairments in social-communication skills. Children and adolescents with social-communication problems face difficulty understanding, interacting and relating with others. University of Missouri researchers found that children who receive more intensive therapy to combat these impairments, especially at early ages, achieve the best outcomes.
More than 90 percent of Americans age 65 and older have prescription drug coverage today, compared to 76 percent who were covered in 2004, according to a University of Michigan analysis.
› Verified 3 days ago
Mr. Young Kim, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Duarte Rd, Duarte, CA 91010 Phone: 626-359-8111 | |
Winston Yuhsien Lee, MD, PHD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1500 Duarte Rd, Duarte, CA 91010 Phone: 626-256-4673 | |
Dr. Bharat Nathwani, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1500 Duarte Rd, Duarte, CA 91010 Phone: 626-256-4673 | |
Dr. Jing Zhai, MD PHD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1500 Duarte Rd, Duarte, CA 91010 Phone: 626-359-8111 | |
Fei Fei, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 1500 Duarte Rd, Duarte, CA 91010 Phone: 800-826-4673 | |
Dr. Juan-sebastian Saldivar, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1500 E Duarte Rd, Duarte, CA 91010 Phone: 626-359-8111 |